공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 글리코믹스(당쇄생물학) 시장 : 성장, 동향, 예측(2020-2025년)

Glycomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2021년 05월 상품 코드 964949
페이지 정보 영문
가격
US $ 4,250 ₩ 5,044,000 PDF (Single User License)
US $ 4,750 ₩ 5,637,000 PDF (Team License: Up to 7 Users)
US $ 6,000 ₩ 7,121,000 PDF (Site License)
US $ 7,500 ₩ 8,901,000 PDF (Corporate License)


세계의 글리코믹스(당쇄생물학) 시장 : 성장, 동향, 예측(2020-2025년) Glycomics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
발행일 : 2021년 05월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

글리코믹스(당쇄생물학) 시장 규모는 예측 기간 중 13.9%의 CAGR로 성장할 것으로 예측되고 있습니다. 이것은 글리콤 및 글리칸과 프로테옴의 분석을 위한 새로운 기술에 관한 연구개발 활동의 증가에 의한 것입니다. 일반적으로 세포 표면에 존재하는 글리칸은 신체의 시스템에서 매우 중요한 역할을 담당합니다. 이것은 많은 유전성 질환의 원인이며, 암의 발생에서 중요한 역할을 담당하고 있습니다. 에리스로포이에틴은 항바이러스 요법에서 사용되는 생물학적 제제로, 3개의 N형당쇄와 1개의 O형 당쇄를 가지고 있습니다. 또한 2017년에 Sciex는 'Fast Glycan Labelling and Analysis Kit'를 발매했습니다. 이것은 주로 N형 당쇄의 정량적 추정에 사용되는 샘플 조제의 시간과 노력을 절약합니다. 따라서 이 요인은 글리코믹스 시장의 성장을 촉진할 것으로 예상됩니다. 그러나 글리코믹스에 관련된 제품의 고비용은 시장의 성장을 방해할 가능성이 있습니다.

세계의 글리코믹스(당쇄생물학) 시장을 조사했으며, 시장의 개요, 시장 성장요인 및 저해요인 분석, 시장 기회, 제품 유형·애플리케이션·지역별 시장 규모의 추이와 예측, 경쟁 구도, 주요 기업의 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 촉진요인
    • 연구개발 활동의 증가
    • 제품의 기술적 진보
  • 시장 저해요인
    • 엄격한 규제 프레임워크
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 제품 유형별
    • 기구
    • 시약과 키트
    • 효소
  • 애플리케이션별
    • 의약품 개발
    • 진단
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타

제6장 경쟁 구도

  • 기업 개요
    • ThermoFisher Scientific Inc.
    • Agilent Technologies Inc.
    • Merck KGaA
    • Bruker
    • New England Biolabs Inc.
    • Danaher(SCIEX)
    • Takara Bio Inc.
    • Waters Corporation
    • QA-Bio
    • Shimadzu Corporation

제7장 시장 기회 및 향후 전망

KSA 20.11.19

The glycomics market is expected to register a CAGR of 13.9% during the forecast period with the increasing research and development activities about glycomes and emerging technology for analysis of glycans and proteomes. Glycans, generally present on the cell surface, plays a very crucial role in the body system. They are responsible for many hereditary diseases and has a vital role in cancer development. Erythropoietin is a biological product used in anti-viral therapy and has three N-glycans and one O-glycan chain. Furthermore, in 2017, Sciex launched "Fast Glycan Labelling and Analysis Kit." It saves time and effort for sample preparation, mostly used in the quantitative estimation of N-glycan. Hence, these factors are expected to drive the glycomics market growth. But the high cost of products related to glycomes may obstruct the glycomes market growth.

Key Market Trends

Drug Discovery and Development Segment is Expected to Hold a Major Market Share in the Glycomics Market

  • As the burden of chronic diseases is increasing, the need for developing new drugs is also increasing. Glycans play a major role in biological processes such as cell-cell interaction and thus have immense importance in drug development. Therefore, often these glycan chains are modified to synthesize drugs. For instance, hyaluronan, a naturally occurring disaccharide unit of glycosaminoglycan, has wide applications into medicine. It is used in post-surgical wounds and has an essential part in osteoarthritis treatment.
  • Furthermore, glycans have wide applications in vaccine development too. Many of the conjugate vaccines are based upon proteins and glycans. For instance, Prevnar 13 (manufactured by Pfizer, Inc.) used for preventing pneumococcal bacterial infection, is based upon glycans.
  • Thus, considering rising research and development, the market is expected to witness healthy CAGR over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to be a dominant region in the glycomics market owing to increasing research and development activities and government funding programs. Recently, the National Institute of Health-funded into the research "Computational and Informatics Resources and Tools for Glycoscience Research." Furthermore, companies are investing heavily in research and development activities, which are expected to propel the growth of glycomics. According to Pharmaceutical Research and Manufacturers of America, in 2018, the pharmaceutical industry spent over USD 79.6 billion on research and development. Thus, it is expected to impact positively on North America's glycomics market.

Competitive Landscape

The glycomics market is fragmented and consists of several major players. Companies are adopting growth strategies in order to develop the glycomics market. For instance, in 2018, Agilent Technologies, Inc. acquired ProZyme, Inc. to expand its product-line into glycome products. ProZyme Inc. is known for its glycobiology products and bioanalytical proteins. Some of the companies which are currently dominating the market are ThermoFisher Scientific Inc., Agilent Technologies Inc., Merck KGaA, Bruker, New England Biolabs Inc., Danaher (SCIEX), Takara Bio Inc., Waters Corporation, QA-Bio, and Shimadzu Corporation.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Research and Development Activities in Glycomics
    • 4.2.2 Technological Advancements in Products
  • 4.3 Market Restraints
    • 4.3.1 Complexity of Glycomics Coupled With The High Cost Involved in the Process
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Instruments
    • 5.1.2 Reagents and Kits
    • 5.1.3 Enzymes
  • 5.2 By Application
    • 5.2.1 Drug Development
    • 5.2.2 Diagnostics
    • 5.2.3 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ThermoFisher Scientific Inc.
    • 6.1.2 Agilent Technologies Inc.
    • 6.1.3 Merck KGaA
    • 6.1.4 Bruker
    • 6.1.5 New England Biolabs Inc.
    • 6.1.6 Danaher (SCIEX)
    • 6.1.7 Takara Bio Inc.
    • 6.1.8 Waters Corporation
    • 6.1.9 QA-Bio
    • 6.1.10 Shimadzu Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q